BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hillman L, Yadlapati R, Thuluvath AJ, Berendsen MA, Pandolfino JE. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease. Dis Esophagus 2017;30:1-15. [PMID: 28859358 DOI: 10.1093/dote/dox055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yadlapati R, DeLay K. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease. Med Clin North Am. 2019;103:15-27. [PMID: 30466671 DOI: 10.1016/j.mcna.2018.08.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
2 Chen R, Qiu Z, Lai K. 2019 ERS cough guideline: consensus and controversy. J Thorac Dis 2020;12:7504-14. [PMID: 33447440 DOI: 10.21037/jtd-2020-065] [Reference Citation Analysis]
3 Rettura F, Bronzini F, Campigotto M, Lambiase C, Pancetti A, Berti G, Marchi S, de Bortoli N, Zerbib F, Savarino E, Bellini M. Refractory Gastroesophageal Reflux Disease: A Management Update. Front Med (Lausanne) 2021;8:765061. [PMID: 34790683 DOI: 10.3389/fmed.2021.765061] [Reference Citation Analysis]
4 Hou M, Hu H, Jin C, Yu X. Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis. Iran J Public Health 2020;49:2264-74. [PMID: 34178733 DOI: 10.18502/ijph.v49i12.4807] [Reference Citation Analysis]
5 Yadlapati R, Pandolfino JE. Personalized Approach in the Work-up and Management of Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am 2020;30:227-38. [PMID: 32146943 DOI: 10.1016/j.giec.2019.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
6 Zhang M, Zhu Y, Dong R, Qiu Z. Gabapentin versus baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough. J Thorac Dis 2020;12:5243-50. [PMID: 33145100 DOI: 10.21037/jtd-2020-icc-002] [Reference Citation Analysis]
7 Arévalo-Galvis A, Otero-Regino WA, Ovalle-Celis GN, Rodríguez-Gómez ER, Trespalacios-Rangel AA. Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17. PLoS One 2021;16:e0245401. [PMID: 33503046 DOI: 10.1371/journal.pone.0245401] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yadlapati R, Vaezi MF, Vela MF, Spechler SJ, Shaheen NJ, Richter J, Lacy BE, Katzka D, Katz PO, Kahrilas PJ. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018;113:980-986. [PMID: 29686276 DOI: 10.1038/s41395-018-0045-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 8.8] [Reference Citation Analysis]